Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Qlife Holding - Chinese partnership deal offers great potential

By HC Andersen Capital
Qlife Holding

Meet and ask questions to CEO Thomas Warthoe from Qlife on 11 December 2023 at 11 AM.

Monday 4 December Qlife Holding announced that its Letter of Intent (LOI) with Hipro Biotechnology, turned into a collaboration agreement. Hipro Biotechnology will sell, distribute, and produce the point-of-care Egoo Health system developed by Olife Holding on the Chinese market, primarily to hospitals of which there are more than 35.000 in China. Hipro Biotechnologies have exposure to 14.000 of those hospitals today.

You’re welcome to send in your questions before the event.

Read more about the agreement here:https://www.inderes.dk/analyst-comments/qlife-holding-chinese-partnership-deal-offers-great-potential

Disclaimer: HC Andersen Capital receives payment from Qlife for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 06/12-2023 10:38 AM.

Recent videos

Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-13 12:50 Orion
A sit-down with CEO Remco Westermann
2025-12-12 09:09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
2025-12-11 11:00 Aiforia Technologies
Endomines as an Investment | Investor Day Nov. 24, 2025
2025-12-10 12:30 Endomines Finland
Clas Ohlson, Audiocast, Q2'25
2025-12-10 09:00 Clas Ohlson
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.